Search Results - "Csilla, Rózsa"
-
1
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
Published in PloS one (22-04-2022)“…Fingolimod was approved and reimbursed by the healthcare provider in Hungary for the treatment of highly active relapsing-remitting multiple sclerosis (RRMS)…”
Get full text
Journal Article -
2
Contributing factors to health‐related quality of life in multiple sclerosis
Published in Brain and behavior (01-12-2019)“…Background Health‐related quality of life (HRQoL) is lower in people with multiple sclerosis (PwMS) compared to the healthy population, psychological symptoms…”
Get full text
Journal Article -
3
Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society
Published in Orphanet journal of rare diseases (07-07-2023)“…Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying…”
Get full text
Journal Article -
4
Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks
Published in Neuromuscular disorders : NMD (01-07-2012)“…Abstract Using the emerging technique of peripheral nerve ultrasonography, multiple focal nerve swellings corresponding to sites of existing conduction blocks…”
Get full text
Journal Article -
5
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary
Published in Multiple sclerosis and related disorders (01-05-2016)“…Abstract Background The common symptoms of multiple sclerosis are fatigue, depression, cognitive dysfunction, pain and sexual dysfunction, which influence the…”
Get full text
Journal Article -
6
Extending therapeutic possibilities in relapsing-remitting multiple sclerosis: dimethyl fumarate
Published in Ideggyógyászati szemle (30-01-2015)“…Dimethyl fumarate (DMF) is a novel oral therapy that has recently been approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Dimethyl…”
Get full text
Journal Article -
7
Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases
Published in Autoimmunity reviews (01-01-2011)“…Neuromyelitis optica (NMO, Devic's disease), an uncommon demyelinating neuro-immunological disease, can be associated with autoimmune diseases. In SLE…”
Get full text
Journal Article -
8
Interleukin-4 receptor alpha polymorphisms in autoimmune myasthenia gravis in a Caucasian population
Published in Human immunology (01-02-2012)“…Abstract Autoimmune myasthenia gravis is a T-cell–dependent, antibody-mediated, rare neuromuscular disorder. Interleukin-4, acting via interleukin-4 receptor…”
Get full text
Journal Article -
9
Health status and costs of ambulatory patients with multiple sclerosis in Hungary
Published in Ideggyógyászati szemle (30-09-2012)“…Data on disease burden of multiple sclerosis from Eastern-Central Europe are very limited. Our aim was to explore the quality of life, resource utilisation and…”
Get full text
Journal Article -
10
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
Published in Annals of neurology (01-03-2015)“…Objective In patients suffering multiple sclerosis activity despite treatment with interferon β or glatiramer acetate, clinicians often switch therapy to…”
Get full text
Journal Article -
11
Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients
Published in Journal of the neurological sciences (15-09-2007)Get full text
Journal Article -
12
Clinical and biological heterogeneity of autoimmune myasthenia gravis
Published in Journal of neuroimmunology (01-02-2011)“…Abstract Although myasthenia gravis (MG) has long been considered a well-established autoimmune disease associated with autoantibodies, which are convincingly…”
Get full text
Journal Article -
13
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
Published in Therapeutic Advances in Neurological Disorders (2020)“…At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and 2019 factors influencing daily treatment choices in MS, especially…”
Get full text
Book Review Journal Article -
14
Management of multiple sclerosis patients in central European countries: current needs and potential solutions
Published in Therapeutic Advances in Neurological Disorders (01-01-2018)“…Multiple sclerosis (MS) experts in Europe are facing rapidly rising demands of excellence due to the increasing complexity of MS therapy and management. A…”
Get full text
Book Review Journal Article -
15
Family planning in multiple sclerosis: conception, pregnancy, breastfeeding
Published in Ideggyógyászati szemle (30-05-2020)Get full text
Journal Article -
16
Utilization of acute vascular imaging and neurointervention for acute ischaemic stroke patients in 20 Hungarian stroke centers
Published in Ideggyógyászati szemle (30-11-2019)“…Acute mortality rate of stroke in Hungary is significantly higher than in Western Europe, which is likely to be partially attributable to suboptimal treatment…”
Get full text
Journal Article -
17
Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome
Published in Multiple sclerosis and related disorders (01-10-2017)“…Cognitive impairment (CI) is a frequent symptom of multiple sclerosis (MS); its prevalence is reported to be 43–70%. It is one of the most important…”
Get full text
Journal Article -
18
Családtervezés sclerosis multiplexben: fogantatás, terhesség, szoptatás
Published in Ideggyógyászati szemle (30-03-2020)Get full text
Journal Article -
19
Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)
Published in CNS neuroscience & therapeutics (01-05-2013)“…Summary Prolonged‐release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central…”
Get full text
Journal Article -
20
Tumour necrosis factor alpha gene (TNF-α) −376 polymorphism in Hungarian patients with primary progressive multiple sclerosis
Published in Journal of neuroimmunology (31-03-2009)“…Abstract Tumour necrosis factor alpha (TNF-α) is associated with clinical activity in relapsing–remitting multiple sclerosis (RRMS) and the development of…”
Get full text
Journal Article